Full Text (PDF)
Indian Journal of Genetics and Molecular Research 11(1):p 29-30, January-June 2022. | DOI: https://doi.org/10.21088/ijgmr.2319.4782.11122.3
Review Article
Efficacy of Growth Hormone in Chronic Kidney Disease
Bandhu Sharma, Vishakha1 , Pragya Sinha, S P Subashini
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Indian Journal of Genetics and Molecular Research 11(1):p 29-30, January-June 2022. | DOI: https://doi.org/10.21088/ijgmr.2319.4782.11122.3
How Cite This Article:
Vishakha, Pragya Sinha, Bandhu Sharma, et. al./Efficacy of Growth Hormone in Chronic Kidney Disease/Indian J Genet Mol Res. 2022; 11(1):29–30.Timeline
Received : March 11, 2022
Accepted : April 01, 2022
Published : June 20, 2022
Abstract
Children with chronic kidney disease (CKD) have difficulty achieving normal growth due to severe alterations in the growth hormone (GH) and insulin-like growth factor (IGF-1) axis. Recombinant human growth hormone (rhGH) therapy (GH). It encourages long-term growth and allows children with CKD to reach normal height. It has been demonstrated to be both safe and effective. After a kidney transplant, growth retardation may remain. Multiple variables, such as steroid use, impaired renal function, and an aberrant GH axis, have contributed to this condition.
References
- 1. Frank field DL, Neu AM, Warady BA, Fivush BjornsonCA, BremAS. Anemia in pediatrichemodialysis patients: Results from the 2001 ESRD clinical Performance Measures Project. Kidney Int.2003; 64:1120-4.
- 2. http://www.cari.org.au/CKD/CKD%20nutrition %20 growth/Evaluation_ and_management_of nutrition. (2005).
- 3. Alexander,R. T. & Bitan, Renal tubular acidosis. Pediatrics. Clinical.North Am.66,135-157(2019).
- 4. Fine, R.N. Stimulating growth in uremic children. Kidney Int.42,188-197 (1992).
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Vishakha, Pragya Sinha, Bandhu Sharma, et. al./Efficacy of Growth Hormone in Chronic Kidney Disease/Indian J Genet Mol Res. 2022; 11(1):29–30.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| March 11, 2022 | April 01, 2022 | June 20, 2022 |
DOI: https://doi.org/10.21088/ijgmr.2319.4782.11122.3
Keywords
Growth hormone; Insulin-like growth factor; Chronic kidney failure; Growth factor; Treatment.Growth hormoneInsulin-like growth factorChronic kidney failureGrowth factorTreatmentSearch for Similar Articles
Similar Articles
- Success After Unexplained Multiple Miscarriages using PGT-A and PGT-M for RELN G...
- A Translational Strategy to Overcome Platinum Resistance in Ovarian Cancer via...
- Bridging Classic Cytogenetics with Modern Chromosomics: A Historical and Scienti...
- Mitochondrial D-Loop and HBB Gene Profiling in Antenatal Hemoglobinopathy Carrie...
- Histopathologic Features of High Grade Serous Ovarian Carcinomas Associated with...
Article Level Metrics
Last UpdatedMonday 22 June 2026, 04:51:37 (IST)
941
Accesses
6
274
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | March 11, 2022 |
| Accepted | April 01, 2022 |
| Published | June 20, 2022 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
